By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Key Statistics

Ownership: Public

Web Site: BioTime
Symbol: BTX

Company News
Bay Area's BioTime (BTX) Launches New Subsidiary AgeX Therapeutics, Inc. to Develop Its Human Aging Programs 4/6/2017 8:36:57 AM
Key BioTime (BTX) Patents Upheld By European Patent Office 3/28/2017 6:44:54 AM
BioTime (BTX) Reports Fourth Quarter And Fiscal Year 2016 Financial Results And Recent Corporate Accomplishments 3/17/2017 6:27:28 AM
Data From BioTime (BTX)’s Opregen Trial In Dry-AMD To Be Presented At Association for Research in Vision & Ophthalmology On May 8 3/15/2017 7:47:52 AM
BioTime (BTX) Expands OpRegen Clinical Trial In Dry-AMD With Opening Of First U.S. Sites 3/13/2017 6:15:19 AM
BioTime (BTX) To Announce Fourth Quarter And Fiscal 2016 Results On March 16, 2017 2/23/2017 6:21:06 AM
BioTime (BTX) Reports Pro Forma Gain On Deconsolidation Of OncoCyte Subsidiary 2/21/2017 6:13:06 AM
BioTime (BTX) Announces Closing Of Public Offering Of Common Stock 2/16/2017 6:57:23 AM
BioTime (BTX) Announces Pricing Of Public Offering Of Common Stock 2/10/2017 7:19:26 AM
BioTime (BTX) Announces Proposed Public Offering Of Common Stock 2/10/2017 6:51:32 AM